Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | GNE | Q9Y223 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | PIM1 | P11309 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine Dicarboxamide SCHEMBL29587789 | 0.91 | TSHR (0.59) | KDM4EALOX15TSHRACMSDTDP1 | |
| Pyridine Dicarboxamide SCHEMBL229425 | 0.91 | TSHR (0.59) | KDM4EALOX15TSHRACMSDTDP1 | |
| Pyridine Dicarboxamide SCHEMBL29501171 | 0.88 | TSHR (0.56) | KDM4EALOX15TSHRACMSDTDP1 | |
| Pyridine Dicarboxamide SCHEMBL29031925 | 0.88 | TSHR (0.56) | KDM4EALOX15TSHRACMSDTDP1 | |
| Pyridine Dicarboxamide SCHEMBL15347496 | 0.88 | TSHR (0.56) | KDM4EALOX15TSHRACMSDTDP1 | |
| Pyridine Dicarboxamide SCHEMBL38659131 | 0.88 | TSHR (0.56) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL720696 | 0.88 | KDM4E (1.00) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL34595 | 0.88 | KDM4E (1.00) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL3732330 | 0.85 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL9491853 | 0.85 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117362628-A | Perfluoro polyether type conductive agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| EP-1125498-B1 | Spore germination inhibitor and food using the same | AJINOMOTO KK (JP) | 2004-08-25 | — | — | EP | claimed |
| US-6506431-B2 | Using 6-carbamoyl-2-pyridine carboxylic acid | AJINOMOTO CO., INC. (JP) | 2003-01-14 | — | — | US | claimed |
| US-20010019720-A1 | Spore germination inhibitor and food using the same | AJINOMOTO CO., INC. (JP) | 2001-09-06 | — | — | US | claimed |
| EP-1125498-A2 | Spore germination inhibitor and food using the same | Ajinomoto Co., Inc. (JP) | 2001-08-22 | — | — | EP | claimed |
| WO-2024222837-A1 | TETRAHYDRONAPHTHYLPROPYLAMINOMETHYLPIPERIDINE ARYL (SULFONYL)AMIDE DERIVATIVE, PREPARATION METHOD, AND APPLICATION THEREOF | 江苏恩华药业股份有限公司 | 2024-10-31 | — | — | WO | disclosed |
| CN-117362628-A | Perfluoro polyether type conductive agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230143425-A1 | IMPROVEMENTS RELATED TO SORBENT MEDIA | GENESIS SYSTEMS LLC | 2023-05-11 | — | — | US | disclosed |
| EP-3212637-B1 | DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS | INDIVIOR UK LTD (GB) | 2021-06-02 | — | — | EP | disclosed |
| EP-3212637-B1 | DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS | INDIVIOR UK LTD (GB) | 2021-06-02 | — | — | EP | disclosed |
| US-10654842-B2 | Dopamine D3 receptor antagonist compounds | INDIVIOR UK LIMITED (GB) | 2020-05-19 | — | — | US | disclosed |
| US-10654842-B2 | Dopamine D3 receptor antagonist compounds | INDIVIOR UK LIMITED (GB) | 2020-05-19 | — | — | US | disclosed |
| US-6506431-B2 | Using 6-carbamoyl-2-pyridine carboxylic acid | AJINOMOTO CO., INC. (JP) | 2003-01-14 | — | — | US | disclosed |
| US-6506431-B2 | Using 6-carbamoyl-2-pyridine carboxylic acid | AJINOMOTO CO., INC. (JP) | 2003-01-14 | — | — | US | disclosed |
| EP-1125498-A3 | Spore germination inhibitor and food using the same | Ajinomoto Co., Inc. (JP) | 2002-08-14 | — | — | EP | disclosed |
| JP-2001302417-A | SPORE GERMINATION INHIBITOR AND FOOD USING THE SAME | AJINOMOTO CO INC | 2001-10-31 | — | — | JP | disclosed |
| US-20010019720-A1 | Spore germination inhibitor and food using the same | AJINOMOTO CO., INC. (JP) | 2001-09-06 | — | — | US | disclosed |
| US-20010019720-A1 | Spore germination inhibitor and food using the same | AJINOMOTO CO., INC. (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-1125498-A2 | Spore germination inhibitor and food using the same | Ajinomoto Co., Inc. (JP) | 2001-08-22 | — | — | EP | disclosed |
| EP-1125498-A2 | Spore germination inhibitor and food using the same | Ajinomoto Co., Inc. (JP) | 2001-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010019720-A1 | Spore germination inhibitor and food using the same | DDC, DAO, AADAT | KDM4E 385/4885ALOX15 2876/4885TSHR 4815/4885 |
| US-10654842-B2 | Dopamine D3 receptor antagonist compounds | DRD3, DRD2, DRD4 | KDM4E 3324/4885ALOX15 3716/4885TSHR 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.